Literature DB >> 34198189

Sub-chronic exposure to antibiotics doxycycline, oxytetracycline or florfenicol impacts gut barrier and induces gut microbiota dysbiosis in adult zebrafish (Daino rerio).

Mingrong Qian1, Jianmei Wang1, Xiaofeng Ji1, Hua Yang1, Biao Tang1, Hu Zhang1, Guiling Yang2, Zhiwei Bao3, Yuanxiang Jin4.   

Abstract

Antibiotics are widely used in the treatment of bacterial infections and as food additives in the livestock industry. The wide usage of antibiotics causes residues in animal products, like milk, eggs and meat. A number of studies have reported that antibiotic residues exist at high concentrations in watercourses around the world. Doxycycline (DH), oxytetracycline (OTCC) and florfenicol (FF) are the three most commonly used veterinary antibiotics in China. However, studies of the toxic effects of DH, OTCC and FF are limited. In this study, six-moth-old healthy male adult zebrafish were exposed to 0, 10, 30, 100 μg/L DH, OTCC or FF for 21 days. After exposure, some biochemical parameters changed significantly, including total cholesterol (TC), triglyceride (TG), pyruvate and acid phosphatase (ACP). In addition, mucus secretion in the gut decreased and the transcription of related genes also decreased significantly. Moreover, the composition of microbiota in the gut changed significantly. DH, OTCC and FF exposure caused the decrease of diversity of gut microbiota. The relative abundance of Proteobacteria increased significantly after OTCC and FF exposure and Fusobacteria decreased in all antibiotic-treated groups. Further functional prediction analysis also suggested changes in gut microbiota in the OTCC and FF-treated groups, especially those linked to metabolism. To support this idea, we confirmed that some glycolipid related genes also increased significantly in the liver of adult zebrafish after antibiotic exposure. According to these results, DH, OTCC or FF exposure could cause the gut microbiota dysbiosis and dysfunction, and hepatic metabolic disorder in adult male zebrafish.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibiotic; Gut barrier; Gut microbiota; Metabolism; Zebrafish

Mesh:

Substances:

Year:  2021        PMID: 34198189     DOI: 10.1016/j.ecoenv.2021.112464

Source DB:  PubMed          Journal:  Ecotoxicol Environ Saf        ISSN: 0147-6513            Impact factor:   6.291


  5 in total

Review 1.  An Overview of Antibiotic Resistance and Abiotic Stresses Affecting Antimicrobial Resistance in Agricultural Soils.

Authors:  Abdullah Kaviani Rad; Angelika Astaykina; Rostislav Streletskii; Yeganeh Afsharyzad; Hassan Etesami; Mehdi Zarei; Siva K Balasundram
Journal:  Int J Environ Res Public Health       Date:  2022-04-12       Impact factor: 4.614

2.  Adapting to Novel Environments Together: Evolutionary and Ecological Correlates of the Bacterial Microbiome of the World's Largest Cavefish Diversification (Cyprinidae, Sinocyclocheilus).

Authors:  Shipeng Zhou; Amrapali P Rajput; Tingru Mao; Yewei Liu; Gajaba Ellepola; Jayampathi Herath; Jian Yang; Madhava Meegaskumbura
Journal:  Front Microbiol       Date:  2022-03-14       Impact factor: 5.640

3.  Development and Validation of Multi-Residue Method for Drugs Analysis in Human Feces by Liquid Chromatography-Tandem Mass Spectrometry.

Authors:  Gabriel Míguez-Suárez; Alejandra Cardelle-Cobas; Laura Sinisterra-Loaiza; Beatriz Vázquez; Alberto Cepeda; Carolina Nebot
Journal:  Molecules       Date:  2022-02-22       Impact factor: 4.411

4.  Probiotic Bacillus safensis NPUST1 Administration Improves Growth Performance, Gut Microbiota, and Innate Immunity against Streptococcus iniae in Nile tilapia (Oreochromis niloticus).

Authors:  Pei-Shan Wu; Chun-Hong Liu; Shao-Yang Hu
Journal:  Microorganisms       Date:  2021-12-01

5.  Exposure to Oxy-Tetracycline Changes Gut Bacterial Community Composition in Rainbow Trout: A Preliminary Study.

Authors:  Aritra Roy Choudhury; Ji-Young Park; Do Young Kim; Jeongyun Choi; Satabdi Acharya; Jung-Ho Park
Journal:  Animals (Basel)       Date:  2021-11-29       Impact factor: 2.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.